Obsidian Therapeutics, Inc. (OBX)
A clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor-infiltrating lymphocyte (TIL) cell therapies for the treatment of patients with solid tumors. Its proprietary cytoDRiVE® technology is designed to precisely regulate the timing and level of protein function by using FDA-approved small-molecule drugs.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Obsidian Therapeutics Inc.
NASDAQ:OBXHealthcare · Biotechnology
-0.86%$13.86
AH Close$13.86+0.00%vs close
AH Close$13.86+0.00%vs close
Mkt Cap$856.17M
Float50.01M
O/S61.77M
Inst Own0.0%
SI1.8%
Dilution
Delisting Issues Timeline
Financials Summary
No financial data available.
Debt & Equity
No debt & equity data available.
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in OBX's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
No balance sheet details available.
Income Statement
No income statement data available.
Balance Sheet
No balance sheet data available.
Cash Flow Statement
No cash flow data available.